Will Retatrutide (new obesity drug) be FDA approved by the end of 2024?
Basic
6
Ṁ456resolved Jan 1
Resolved
NO1D
1W
1M
ALL
This question is managed and resolved by Manifold.
Get
1,000
and3.00
Sort by:
Phase 3 trial is estimated to complete in late 2025: https://classic.clinicaltrials.gov/ct2/show/NCT05882045
Related questions
Related questions
Will Retatrutide (new obesity drug) be FDA approved by the end of 2025?
36% chance
Will Retatrutide (new obesity drug) be FDA approved by the end of 2026?
85% chance
Will AOH1996 be FDA approved before 2040?
44% chance
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
58% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
66% chance
Will an AI-designed drug get FDA approval by the end of 2025?
30% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will a drug that didn't go through human clinical trials be approved by 2034?
29% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
80% chance
Affordable weight loss drugs before 2030?
76% chance